Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

被引：0

作者：

L. Poetsch

C. Bronnimann

H. Loiseau

J. S. Frénel

A. Siegfried

R. Seizeur

G. Gauchotte

D. Cappellen

C. Carpentier

D. Figarella-Branger

S. Eimer

D. Meyronet

F. Ducray

机构：

[1] Service d’Oncologie Médicale,Neuro

[2] CHU de Bordeaux- Hôpital Saint André,oncology Department

[3] Service de Neurochirurgie B,undefined

[4] CHU de Bordeaux - Hôpital Pellegrin,undefined

[5] EA 7435 – IMOTION (Imagerie moléculaire et thérapies innovantes en oncologie) Université de Bordeaux,undefined

[6] Institut de Cancérologie de l’Ouest,undefined

[7] Centre René Gauducheau,undefined

[8] Service de Pathologie,undefined

[9] Institut Universitaire du Cancer de Toulouse Oncopole,undefined

[10] Service de Neurochirurgie,undefined

[11] Hôpital de la Cavale Blanche,undefined

[12] CHRU de Brest,undefined

[13] Université de Brest,undefined

[14] Service d’Anatomie et Cytologie Pathologiques,undefined

[15] CRB BB-0033-00035,undefined

[16] CHRU de Nancy,undefined

[17] INSERM U1256,undefined

[18] Université de Lorraine,undefined

[19] U1035 Inserm - Biothérapie des Maladies Génétiques,undefined

[20] Inflammatoires et Cancers (BMGIC),undefined

[21] Univ. Bordeaux,undefined

[22] Service de Biologie des Tumeurs,undefined

[23] CHU de Bordeaux - Hôpital du Haut Lévêque,undefined

[24] AP-HP,undefined

[25] Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix,undefined

[26] Service de Neurologie 2-Mazarin,undefined

[27] Sorbonne Université,undefined

[28] Inserm,undefined

[29] CNRS,undefined

[30] UMR S 1127,undefined

[31] Institut du Cerveau et de la Moelle Epiniere,undefined

[32] ICM,undefined

[33] Aix-Marseille Univ,undefined

[34] APHM,undefined

[35] CNRS,undefined

[36] INP,undefined

[37] Inst Neurophysiopathol,undefined

[38] CHU Timone,undefined

[39] Service d’Anatomie Pathologique et de Neuropathologie,undefined

[40] Service de Pathologie,undefined

[41] CHU de Bordeaux,undefined

[42] Hôpital Pellegrin,undefined

[43] Centre de Recherche en Cancérologie de Lyon,undefined

[44] INSERM U1052,undefined

[45] CNRS UMR 5286,undefined

[46] Cancer Cell Plasticity department,undefined

[47] Université Claude Bernard Lyon 1,undefined

[48] Hospices Civils de Lyon,undefined

来源：

Journal of Neuro-Oncology | 2021年 / 151卷

关键词：

Non-canonical IDH mutant gliomas; Inherited predisposition to cancer; Infra-tentorial gliomas; Multicentric gliomas;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：279 / 286

页数：7

共 50 条

[41] MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA
Spitzer, Avishay
Gritsch, Simon
Nomura, Masashi
Jucht, Alexander
Fortin, Jerome
Raviram, Ramya
Weisman, Hannah R.
Castro, L. Nicolas Gonzalez
Druck, Nicholas
Chanoch-Myers, Rony
Lee, John J. Y.
Mylvaganam, Ravindra
Servis, Rachel Lee
Fung, Jeremy Man
Lee, Christine K.
Nagashima, Hiroaki
Miller, Julie J.
Arrillaga-Romany, Isabel
Louis, David N.
Wakimoto, Hiroaki
Pisano, Will
Wen, Patrick Y.
Mak, Tak W.
Sanson, Marc
Touat, Mehdi
Landau, Dan A.
Ligon, Keith L.
Cahill, Daniel P.
Suva, Mario L.
Tirosh, Itay
NEURO-ONCOLOGY, 2024, 26
[42] Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Spitzer, Avishay
Gritsch, Simon
Nomura, Masashi
Jucht, Alexander
Fortin, Jerome
Raviram, Ramya
Weisman, Hannah R.
Castro, L. Nicolas Gonzalez
Druck, Nicholas
Chanoch-Myers, Rony
Lee, John J. Y.
Mylvaganam, Ravindra
Servis, Rachel Lee
Fung, Jeremy Man
Lee, Christine K.
Nagashima, Hiroaki
Miller, Julie J.
Arrillaga-Romany, Isabel
Louis, David N.
Wakimoto, Hiroaki
Pisano, Will
Wen, Patrick Y.
Mak, Tak W.
Sanson, Marc
Touat, Mehdi
Landau, Dan A.
Ligon, Keith L.
Cahill, Daniel P.
Suva, Mario L.
Tirosh, Itay
CANCER CELL, 2024, 42 (05) : 904 - 914.e9
[43] Targeting IDH-Mutant Glioma
Miller, Julie J.
NEUROTHERAPEUTICS, 2022, 19 (06) : 1724 - 1732
[44] Targeting IDH-Mutant Glioma
Julie J. Miller
Neurotherapeutics, 2022, 19 : 1724 - 1732
[45] Aggressiveness of astrocytoma IDH-mutant
Deacu, M.
Docu, A. A.
Popescu, S.
Topliceanu, S. T.
Aschie, M.
Bosoteanu, M.
Cozaru, G. C.
Voda, R. I.
Orasanu, C. I.
VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S315 - S316
[46] FET PET uptake characteristics in IDH-mutant glioma
Barci, E.
Forbig, R.
Mueller, K. J.
Kunte, S.
Kaiser, L.
Schichor, C.
Harter, P.
Preusser, M.
von Baumgarten, L.
Thon, N.
Albert, N. L.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S32 - S32
[47] Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Wollring, Michael M.
Werner, Jan-Michael
Ceccon, Garry
Lohmann, Philipp
Filss, Christian P.
Fink, Gereon R.
Langen, Karl-Josef
Galldiks, Norbert
JOURNAL OF NEURO-ONCOLOGY, 2023, 162 (03) : 481 - 488
[48] Headway against Brain Tumors with Molecular Targeting of IDH-Mutant Gliomas
Schiff, David
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (07): : 653 - 654
[49] TERT expression increases with tumor grade in a cohort of IDH-mutant gliomas
Jalasutram, Anvesh
Caniglia, John L.
Velpula, Kiran K.
Guda, Maheedhara R.
Bach, Sarah E.
Tsung, Andrew J.
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (01): : 295 - 303
[50] Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Shirahata, Mitsuaki
Ono, Takahiro
Stichel, Damian
Schrimpf, Daniel
Reuss, David E.
Sahm, Felix
Koelsche, Christian
Wefers, Annika
Reinhardt, Annekathrin
Huang, Kristin
Sievers, Philipp
Shimizu, Hiroaki
Nanjo, Hiroshi
Kobayashi, Yusuke
Miyake, Yohei
Suzuki, Tomonari
Adachi, Jun-ichi
Mishima, Kazuhiko
Sasaki, Atsushi
Nishikawa, Ryo
Bewerunge-Hudler, Melanie
Ryzhova, Marina
Absalyamova, Oksana
Golanov, Andrey
Sinn, Peter
Platten, Michael
Jungk, Christine
Winkler, Frank
Wick, Antje
Haenggi, Daniel
Unterberg, Andreas
Pfister, Stefan M.
Jones, David T. W.
van den Bent, Martin
Hegi, Monika
French, Pim
Baumert, Brigitta G.
Stupp, Roger
Gorlia, Thierry
Weller, Michael
Capper, David
Korshunov, Andrey
Herold-Mende, Christel
Wick, Wolfgang
Louis, David N.
von Deimling, Andreas
ACTA NEUROPATHOLOGICA, 2018, 136 (01) : 153 - 166

← 1 2 3 4 5 →